Esophageal Cancer Market Size, Share, Growth Trends and Report 2023-2030

Market Overview:
The Global Esophageal Cancer Market growing at a high CAGR during the forecast period 2023-2030.
Esophageal cancer, also known as esophageal carcinoma, is a type of cancer that originates from the tissues of the esophagus. Chronic consumption of tobacco and alcohol, as well as the presence of Barrett's esophagus disease, are among the various factors that can increase the risk of developing esophageal cancer.
Due to its significance in the healthcare sector, it is expected to become more prevalent in the forecast period. More men are affected by esophageal cancer than women. Esophageal cancer is mostly observed in low-income countries.

Download a Free PDF Sample - https://www.datamintelligence.com/download-sample/esophageal-cancer-market

Market Drivers:
Growing research efforts are driving the market growth
The market for esophageal cancer is expected to grow in the coming years, driven by increased spending on research and development for identifying new drugs to treat the disease. Industry leaders are introducing new products, and governments and non-profit organizations are making efforts to raise public awareness about esophageal cancer in some countries.

Esophageal cancer research has gained renewed interest from oncologists and other cancer specialists due to the various diseases it can lead to, and the rising prevalence of cancer caused by exposure to carcinogens found in certain diets. Therefore, the expansion of the global esophageal cancer market depends largely on the medical industry's initiatives to reduce the prevalence of the disease.

Market Opportunities:
The market for esophageal cancer is expected to grow globally in the coming years due to increased investment in pharmaceuticals from emerging markets, a growing focus on providing "patient-centred" care, which is expected to lead to the development of more effective drugs and advancements in research and development technology, high unmet demands, which may result in the entry of new players and the acceptance of new treatments, and technological breakthroughs.

Market Segmentation Analysis:
The global esophageal cancer market is segmented by type into adenocarcinomas, gastrointestinal stromal tumors, carcinoid tumors, squamous cell carcinoma, and others; by therapy into targeted therapy, immunotherapy, chemotherapy; by route of administration into oral, parenteral, others; by end-user into hospitals, clinics, ambulatory surgical centers.

Based on type, Esophageal squamous-cell carcinoma (ESCC) is the leading cause of esophageal cancer worldwide and accounted for the highest revenue in the market in 2022. According to the National Institute of Health, approximately 90% of the new cases of esophageal cancer each year are ESCC.

The disease is prevalent in Eastern and Central Asia, the Rift Valley in Eastern Africa, and Southern Africa. Different factors contribute to ESCC in different areas. While early research linked cigarette smoking and strong alcohol consumption to high ESCC rates in France, these factors cannot fully account for the high frequency in other countries.

Esophageal Cancer Industry Developments
May 2023, Amgen collaborators at the Association of Black Cardiologists (ABC) and Morehouse School of Medicine (MSM) have started the African American Heart Study to check out the association between Lp (a) and atherosclerotic cardiovascular disease (ASCVD). Five thousand African Americans from the United States will participate in the study. Atherosclerotic cardiovascular disease (ASCVD) involves cardiac arrest and cerebrovascular accident, both caused by cholesterol plaque in the arteries.

For more detailed information - https://www.datamintelligence.com/research-report/esophageal-cancer-market

Geographical Analysis:
The global Esophageal Cancer Market is analyzed across North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.
North American region holds the largest market share global Esophageal Cancer Market
The North American region holds the largest market share in the global esophageal cancer market in 2021, mainly due to the increasing prevalence of esophageal cancer in this region. According to the American Cancer Society's report, around 17,650 new cases of esophageal cancer (13,750 in men and 3,900 in women) are expected to be diagnosed in the U.S. by 2021.

Major Companies in the Market Include:
Some of the key players which are contributing to the growth of the market include
1. Amgen Inc.
2. Eli Lilly and Company
3. Hoffmann-La Roche
4. Bristol-Myers Squibb Company
5. Boehringer Ingelheim GmbH

Trending Reports
Nasopharyngeal Cancer Market - https://www.datamintelligence.com/research-report/nasopharyngeal-cancer-market
Endometrial Cancer Market - https://www.datamintelligence.com/research-report/endometrial-cancer-market
Skin Cancer Market - https://www.datamintelligence.com/research-report/skin-cancer-market
Colorectal Cancer Drugs Market - https://www.datamintelligence.com/research-report/colorectal-cancer-drugs-market
Pituitary Cancer Market - https://www.datamintelligence.com/research-report/pituitary-cancer-market

Contact Us:
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence:
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.